Aug 21 (Reuters) - AroCell AB (publ) AROC.ST :
* AROCELL RECEIVES A DECISION TO GRANT FOR A EUROPEAN PATENT
APPLICATION
* EPO HAS ISSUED A DECISION TO GRANT FOR PATENT APPLICATION
NO. 19
163 949.1 AND ENTITLED "MONOCLONAL ANTI-TK1 ANTIBODIES", WHICH
WILL BE PUBLISHED ON 16 SEPTEMBER 2020.
* PATENT APPLICATION RELATES TO AROCELLS PROPRIETARY
MONOCLONAL
ANTIBODIES USED FOR DETERMINING THYMIDINE KINASE 1 CONCENTRATION
IN SERUM SAMPLES
Source text: https://bit.ly/2FKSJTn
Further company coverage: AROC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))